WeVote
Log In

Bill

Bill

HF 464

Dispensing fee requirements imposed on health plan companies and county-based purchasing plans providing prescription drug coverage in the medical assistance program.

2025-2026 Regular Session Introduced by Bobbie Harder

HF 464 establishes mandatory dispensing fee rules for prescription drug coverage under Minnesota's Medical Assistance, affecting insurers and county plans.

Introduction and first reading, referred to Health Finance and Policy
#drugsandmedicine #humanservicesandhumanservicesdepartment #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · HF 464

Summary of HF 464 (2025-2026 Session, Minnesota)

Bill Overview

  • Title: Dispensing fee requirements imposed on health plan companies and county-based purchasing plans providing prescription drug coverage in the medical assistance program
  • Jurisdiction: Minnesota
  • Session: 2025-2026
  • Introduced: February 13, 2025 (First Reading)
  • Primary Sponsors:
    • Co-sponsor: Bobbie Harder
  • Committee Referral: Health Finance and Policy

Purpose and Intent

HF 464 seeks to regulate the dispensing fees charged by two types of entities that provide prescription drug coverage within Minnesota’s Medical Assistance program:
1. Health plan companies
2. County-based purchasing plans

The bill aims to establish standards for dispensing fees tied to prescription drugs under medical assistance, with the goal of ensuring predictable costs for beneficiaries and state programs, and potentially aligning dispensing fees with public program policy objectives.

Key Provisions and Changes (Proposed)

While the bill text is not provided here, the title indicates the substantive focus:
- Dispensing Fee Requirements: Establishes mandatory dispensing fee rules for prescription drug coverage offered through:
- Health plan companies within the Medical Assistance program
- County-based purchasing plans that provide prescription drug coverage under Medical Assistance
- Scope of Coverage: Applies specifically to prescription drug coverage that is part of Minnesota’s Medical Assistance program (the state Medicaid program and related health services).
- Administrative Standards: Likely sets criteria for how dispensing fees are calculated, disclosed, capped, or reviewed (exact mechanics would be in the bill text).
- Compliance and Enforcement: Provisions probably include compliance timelines, reporting requirements, and potential penalties or remedies for noncompliance.

Who Would Be Affected

  • Health Plan Companies: Insurers and health plans administering prescription drug benefits under Minnesota Medical Assistance would need to adjust dispensing fee structures to meet the bill’s requirements.
  • County-Based Purchasing Plans: Local government or collaboratives operating county-based purchasing arrangements for medical assistance prescription drug coverage would be subject to the new dispensing fee standards.
  • Medicaid Beneficiaries/Recipients: Indirectly affected through potential changes in out-of-pocket costs, formularies, and access if dispensing fees influence overall drug costs or plan design.

Procedural and Timeline Aspects

  • Introduction: February 13, 2025, first reading.
  • Next Steps: The bill would advance through the committee process in Health Finance and Policy, where it would be examined for fiscal impact, 财务 implications, compliance details, and stakeholder input. It may be amended before any potential floor vote or passage.
  • Fiscal Impact: The summary requires the bill’s fiscal note to assess state costs or savings associated with implementing dispensing fee requirements, as well as any potential impact on Medicaid expenditures and beneficiaries.

Potential Implications

  • Budgetary: Depending on dispensing fee mandates, there could be changes to state Medicaid drug costs and reimbursement patterns for pharmacies.
  • Access and Affordability: If dispensing fees are standardized or capped, beneficiaries’ total drug costs could be affected, which may influence affordability and adherence.
  • Provider and Pharmacy Practices: Pharmacy networks and dispensing operations may need to adjust pricing disclosures, reimbursements, and contract terms with health plans and county purchasing entities.

Note: The above reflects the bill’s stated title and typical implications of dispensing-fee regulation within medical assistance programs. The exact provisions, numerical thresholds, caps, timelines, and enforcement mechanisms would be detailed in the full bill text and any fiscal notes accompanying it.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.